Taiko Pharmaceutical Co., Ltd.(JP:4574)
¥259.00-2.00 (-0.77%)
JP:4574
Taiko Pharmaceutical Co., Ltd. Revenue
¥259.00
At close:-2.00 (-0.77%)
Want to see JP:4574 full AI Analyst Report?
Taiko Pharmaceutical Co., Ltd. (4574) Revenue
0 Followers
Taiko Pharmaceutical Co., Ltd. Revenue
Taiko Pharmaceutical Co., Ltd. had a revenue of 1.72B in the quarter ending Jun 30, 2026, with 87.77%. This bring the company's revenue in the last twelve months to 6.62B, Increased 7.43%. In the fiscal year ending Dec 31, 2025, Taiko Pharmaceutical Co., Ltd. had annual revenue of 6.40B with 1.67% growth.
- Revenue (ttm)
- 6.62B
- Revenue Growth
- 13.30%
- P/S Ratio
- 2.04
- Revenue/Employee
- JPY 29,077,273
- Employees
- 220
- Market Cap
- JPY 13.07B
Revenue Chart
Taiko Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.40B | 105.00M | 1.67% |
| Dec 31, 2024 | 6.29B | 172.00M | 2.81% |
| Dec 31, 2023 | 6.12B | 1.08B | 21.43% |
| Dec 31, 2022 | 5.04B | -5.68B | -52.99% |
| Dec 31, 2021 | 10.72B | -6.96B | -39.38% |
| Mar 31, 2021 | 17.68B | 2.75B | 18.40% |
| Mar 31, 2020 | 14.94B | 4.56B | 43.93% |
| Mar 31, 2019 | 10.38B | 939.28M | 9.95% |
| Mar 31, 2018 | 9.44B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.